Sean Elmer

And in fact, since August last year, about 50% of its value has

Alongside the re-rating, it has had a rough trot.

It's disappointed at earnings times and downgraded profit forecasts, but it's had a lot of headwinds.

Competitive pressures in its core plasma group has really hurt it.

There are other big players out there now.

Falling vaccine rates in the US, that hasn't helped by the Trump administration and Kennedy being the representative, I mean, being an anti-vaxxer running the health department doesn't help CSL.

The thing for CSL, it just doesn't seem to have any idea how to stem the bleeding.

And pardon the pun.

But yesterday was a shocking day for that company.

And you're just not sure where it bottoms out.

As you said, $100 billion.

So it went from about $150 billion company to what?

It's worth $48 billion now.

Incredible.

I was looking at it.

There's only five companies on the exchange, BHP and the four banks, that are worth more than $100 billion.

Now, CSL has lost $100 billion in value in two years.

So if you want to get a concept about how much it's fallen, that's it.

It's wiped out.

Any other company bar those top five would be worth zero at the moment.